Rank #7 in Chemical
These four scores are AlphaGen model outputs, not company-reported figures.
Wah Nobel Chemicals finished FY26 with a striking split between operations and the bottom line. Revenue declined, but the cost of sales fell much faster, lifting gross and operating margins materially. The implied June quarter was even stronger at the operating level: gross profit more than doubled and operating profit rose by roughly 118% despite lower sales. Yet profit after tax still declined because the year-end tax charge absorbed much of that operating improvement.
The balance sheet and cash-flow picture improved more clearly. Short-term borrowings were eliminated by year-end, inventory was lower, current liabilities fell sharply, and operating cash flow swung from negative to strongly positive. The main question for the next cycle is whether the exceptional Q4 margin level can persist once the full annual report explains the year-end cost and tax movements in more detail.
The biggest improvement was gross conversion. Full-year revenue declined by Rs260.7m, but cost of sales fell by about Rs415.0m. That widened gross profit by Rs154.3m and added roughly 4.1 percentage points to gross margin. This was not a story of selling more; it was a story of retaining more gross profit from each rupee of sales.
The implied Q4 makes the change even clearer. Subtracting the official nine-month result from the official full-year result gives Q4 revenue of about Rs1.10bn versus Rs1.20bn a year earlier. Cost of sales, however, fell about 27.5% to Rs747.0m. Gross profit consequently rose to roughly Rs351.4m from Rs172.8m, and gross margin expanded by more than 17 percentage points to about 32%. The year-end filing does not include Note 22 or management commentary explaining the Q4 cost movement, so it would be speculative to attribute this specifically to methanol, urea, product pricing, utilization or customer mix. What the public numbers establish is that cost compression, not revenue growth, drove the quarter's margin rebound.
Operating leverage followed. Administrative expenses and selling and distribution costs were both modestly lower for the year, allowing most of the gross-profit improvement to reach operating profit. FY26 operating profit increased 19.9% to Rs955.4m even though sales contracted. The implied Q4 operating margin reached about 31.2% versus 13.1% a year earlier.
Cash conversion also improved substantially. Cash generated from operations before fund, interest and tax payments rose to Rs852.7m from Rs104.4m. Net operating cash flow was positive Rs518.3m versus an outflow of Rs368.5m in FY25. The working-capital drag narrowed to Rs180.0m from Rs767.3m: inventory released Rs207.3m of cash, and the trade-debt outflow was only Rs72.1m compared with Rs548.6m a year earlier. This is a meaningful improvement because the profit recovery was accompanied by actual cash generation rather than only accrual earnings.
The balance sheet ended the year with less financing pressure. Short-term borrowings were reduced from Rs452.2m to nil, the current portion of long-term financing also fell to nil, current liabilities declined 58.7% to Rs475.9m, and equity rose 13.7% to Rs3.02bn. Inventory was 18.4% lower at Rs918.3m. Trade debts were broadly stable, up only 1.4% to Rs1.79bn, which is a far better outcome than the heavy receivable build seen in the prior year.
Top-line momentum remains weak. FY26 revenue fell 5.1%, and the implied Q4 decline was steeper at 8.7%. At the nine-month stage, management had already reported a 4% sales decline and attributed the pressure primarily to regional geopolitical developments and disruptions in cross-border trade flows that affected demand and logistics. The fourth quarter did not reverse that revenue pressure, even though profitability improved sharply.
The tax line is the central reason operating improvement did not translate into higher net profit. Full-year taxation increased to Rs364.9m from Rs233.6m, lifting the effective tax burden to about 44.7% of pre-tax profit from 32.6%. More importantly, the implied Q4 tax charge was about Rs157.1m, or roughly 55.5% of implied pre-tax profit, versus an implied tax credit of around Rs1.2m in Q4 FY25. The year-end result references a tax note but does not include the underlying note disclosure, so the specific composition of the Q4 charge cannot yet be verified. Until the annual report is available, this should be treated as a material year-end tax effect rather than assigned to a particular recurring or one-off tax item.
Finance cost also moved against the business on a full-year basis. It rose 141% to Rs43.2m from Rs17.9m. The cash-flow statement shows why a zero year-end debt balance does not mean financing was absent during the year: the company received Rs1.041bn from its parent and repaid the same amount, while interest paid to the parent was Rs32.8m. At March 31, the company still carried an unsecured Rs296.8m parent-company loan. By June, those borrowings had been cleared, and implied Q4 finance cost was only about Rs2.0m versus Rs9.3m a year earlier. That suggests the financing drag eased late in the year, but the next quarter is needed to confirm whether the lower run-rate persists.
Other non-operating lines were less supportive as well. Other income fell 58.2% for FY26 to Rs13.6m, while other expenses rose 11.9% and the allowance for expected credit losses rose 16.3%. These items did not overturn the core margin improvement, but they reinforce the point that the operating line was stronger than the final PAT comparison.
Wah Nobel Chemicals manufactures urea-formaldehyde moulding compounds, formaldehyde and formaldehyde-based liquid resins used as bonding agents in chipboard, plywood and flush-door manufacturing. That makes Dynea Pakistan a useful operating peer because Dynea also manufactures formaldehyde, urea/melamine formaldehyde and moulding compounds.
The peer comparison is informative but mixed. Dynea's FY26 net turnover rose 18.3% and its gross profit rose 25.0%, with gross margin improving to 18.69% from 17.68%. Wah Nobel, by contrast, saw revenue decline 5.1% while its gross margin expanded more sharply to 20.85%. This suggests that margin improvement was not unique to Wah Nobel, but Wah Nobel's weaker sales outcome was not simply an unavoidable sector-wide demand pattern. That is an inference from peer results, not a management explanation of customer or product mix.
The broader industrial backdrop was also uneven. Pakistan Bureau of Statistics data for FY26 showed overall large-scale manufacturing up 4.98%, but later sector detail reported chemicals output down 2.44% and chemical products down 3.96% for 2025-26. That supports management's description of a difficult operating environment, while the much stronger performance of the closest listed peer shows that company-specific execution and mix still mattered.
Year-end liquidity improved on the liability side even though cash itself declined. Cash and bank balances were Rs103.4m versus Rs153.5m a year earlier, but current liabilities fell much faster than current assets. Current assets were Rs2.97bn against current liabilities of Rs475.9m, implying a current ratio of about 6.2x versus roughly 2.8x in FY25. The improvement came largely from clearing short-term borrowings and reducing payables, not from accumulating cash.
The cash-flow statement also shows that FY26's stronger cash generation was helped by much lower capital spending. Capital expenditure fell to only Rs6.1m from Rs190.0m in FY25. That makes the Rs518.3m operating cash inflow valuable, but it also means the improvement in free cash availability reflects both better working-capital conversion and a lighter reinvestment year. The next annual cycle should show whether the company can sustain cash generation if capital spending normalizes.
The Board's Rs5-per-share final dividend is half the Rs10-per-share final dividend reported for FY25. With FY26 EPS of Rs50.19, the proposed payout is modest relative to earnings and consistent with retaining more cash despite the improved year-end balance sheet.
The most recurring-looking improvement is the better gross and operating conversion because it sits within the core revenue-and-cost structure rather than depending on other income. However, the Q4 margin level is unusually high relative to the rest of the year and has no note-level public explanation yet, so it should not automatically be annualized.
The lower implied Q4 finance cost could become recurring if the company remains free of short-term borrowing, but FY26's full-year finance cost demonstrates that intra-year funding can still matter even when the closing balance is zero. Conversely, the unusually heavy Q4 tax charge is a clear distortion between pre-tax and after-tax performance. Without Note 28 from the annual report, it is not possible to determine how much of that charge is recurring versus year-end adjustment.
Cash-flow improvement is encouraging but partly working-capital-driven. Inventory released cash and the trade-debt build was much smaller, while the company also sharply reduced capital expenditure. A durable earnings-quality improvement would require positive operating cash flow to continue without relying on another large inventory unwind or persistently depressed investment spending.
Overall, Wah Nobel Chemicals ended FY26 with materially better core profitability and a much cleaner financing position than the headline PAT decline suggests. The operating story is positive: costs fell faster than revenue, margins widened, debt was cleared and cash conversion improved. The caution lies in the top line, the sustainability of the exceptionally strong Q4 margin, and a year-end tax charge that prevented the operating gains from reaching shareholders' earnings. The next result cycle should clarify whether FY26's margin repair is becoming a durable operating reset or was concentrated in the closing quarter. This analysis is informational and does not constitute buy or sell advice.